Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
May 18, 2020
First Subjects Dosed in Australian Phase I Clinical Study of a Denosumab Biosimilar
May 14, 2020
Oncopeptides Announces New Clinical and Preclinical Melflufen Data at the Upcoming European Hematology Association Meeting
May 14, 2020
Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms
May 13, 2020
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months
May 13, 2020
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors
May 13, 2020
Age-Related Macular Degeneration Markets, Pipeline, Drugs and Companies: 2016-2024
May 13, 2020
Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio
May 12, 2020
Aridis Pharmaceuticals Announces First Quarter 2020 Results
May 12, 2020
Ulcerative Colitis Market Report 2020: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares through 2016-2024
May 08, 2020
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance
May 06, 2020
Targovax Announces That Abstract on Interim Phase I Clinical Data From the Phase I/II Peritoneal Trial is Accepted at ASCO
May 05, 2020
AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan
May 01, 2020
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO(TM) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma
Apr 30, 2020
Halozyme Announces Janssen's Receipt Of CHMP Positive Opinion For DARZALEX® Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma
Apr 29, 2020
Regeneron Announces Upcoming Investor Conference Presentations
Apr 29, 2020
UCB's Cimzia is Making Inroads in the Treatment of Axial Disease, with Significant Uptake in Non-Radiographic Axial Spondyloarthritis and a Positive Treatment Halo in Ankylosing Spondylitis
Apr 29, 2020
RemeGen Announces US FDA Clearance of IND Application to Initiate Phase II Clinical Trial in Urothelial Cancer
Apr 29, 2020
Teva Canada announces the launch of AJOVY(TM) for the preventive treatment of migraine in adults who have at least four migraine days per month
Apr 27, 2020
I-SPY2 TRIAL Demonstrates Significant Improvement in pCR with Durvalumab and Olaparib with Paclitaxel, (Compared to Chemotherapy Alone) in Women with Stage II/III High-Risk, HER2-Negative Breast Cancer, in HR+ and TNBC Subsets
Apr 27, 2020
Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-19 Patients
‹‹
Page 3
››
Latest News
Mar 28, 2024
Slip Robotics Wins Best New Innovation in the Supply Chain at MODEX 2024
Mar 28, 2024
South Africa Motor Vehicle Industry Report 2023: Muted Domestic Sales and Export Slowdown Propose Challenges...
Mar 28, 2024
Gresham Worldwide, Inc. Announces New Head of Israeli Defense Subsidiary
Mar 28, 2024
Solace Capital Partners Provides Growth Capital to Siprocal
Mar 28, 2024
Cognyte to Announce Fourth Quarter and Full Year FY2024 Financial Results on April 9, 2024
Mar 28, 2024
Iveda Finds 84% of Americans Are Concerned About Violence in The Country; Many Believe AI Could Help
Mar 28, 2024
Voltera Welcomes Marie Robinson to Its Board of Directors
Mar 28, 2024
Former Army Maj. Gen. John B. Richardson IV Joins USAA To Lead Military Affairs
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events